| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Chief Development Officer
1 company
Yea Christopher is a Chief Development Officer at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $6.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 4,331 | $13.45 | $58,256.28 | -1.9% | +16.5% | - | |
| Nov 18, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,683 | $14.48 | $38,848.23 | -2.0% | +5.0% | - | |
| Aug 25, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,954 | $13.42 | $26,222.68 | -1.5% | +2.8% | - | |
| Aug 22, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,362 | $13.22 | $31,232.25 | -1.8% | -2.9% | - | |
| Aug 18, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,649 | $13.19 | $34,932.36 | -2.0% | +11.4% | - | |
| Jul 9, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 30,250 | $15.69 | $474,698.13 | -19.1% | -31.7% | - | |
| May 23, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,926 | $11.31 | $21,781.71 | -1.9% | +13.0% | +133.6% | |
| May 22, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,317 | $11.88 | $27,515.53 | -2.3% | +13.0% | +134.6% | |
| May 19, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,600 | $11.84 | $30,791.28 | -2.6% | +10.5% | +121.8% | |
| Feb 24, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,918 | $10.02 | $19,218.36 | -2.0% | +8.3% | +52.2% |